Page 130 - 80 guidelines for the treatment of malaria_opt

nd
Guidelines for the treatment of malaria – 2 edition

12. Pukrittayakamee S et al. Activities of artesunate and primaquine against asexual- and
sexual-stage parasites in falciparum malaria. Antimicrobial Agents and Chemotherapy,
2004, 48:1329–1334.
13. Chotivanich K et al. Transmission-blocking activities of quinine, primaquine, and
artesunate. Antimicrobial Agents and Chemotherapy, 2006, 50:1927–1930.
14. Shekalaghe S et al. Primaquine clears submicroscopic Plasmodium falciparum gametocytes
that persist after treatment with sulphadoxine-pyrimethamine and artesunate. PLoS ONE,
2007, 2:e1023.
15. Githeko, AK et al. The reservoir of Plasmodium falciparum malaria in a holoendemic area
of western Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1992,
86:355–358.
16. Handunnetti et al. Features of recrudescent chloroquine-resistant Plasmodium falciparum
infections confer a survival advantage on parasites, and have implications for disease
control. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1996, 90:563–567.
17. Hallett RL et al. Combination therapy counteracts the enhanced transmission of drug-
resistant malaria parasites to mosquitoes. Antimicrobial Agents and Chemotherapy, 2004,
48:3940–3943.
18. De Roode JC et al. Host heterogeneity is a determinant of competitive exclusion or
coexistence in genetically diverse malaria infections. Proceedings of the Royal Society of
London, Series B, Biological Sciences, 2004. 271:1073–1080.
19. De Roode JC et al. Competitive release of drug resistance following drug treatment of mixed
Plasmodium chabaudi infections. Malaria Journal, 2004, 3:33–42.
20. Molyneux DH et al. Transmission control and drug resistance in malaria: a crucial
interaction. Parasitology Today, 1999, 15:238–240.
21. Mharakurwa S et al. Association of house spraying with suppressed levels of drug resistance
in Zimbabwe. Malaria Journal, 2004, 3:35.
22. Nosten F et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium
falciparum malaria and mefloquine resistance in western Thailand: a prospective study.
Lancet, 2000, 356:297–302.
23. Hastings IM. Gametocytocidal activity in antimalarial drugs speeds the spread of drug
resistance, Tropical Medicine and International Health, 2006, 11:1206–1217.
24. White NJ, Olliaro PL. Strategies for the prevention of antimalarial drug resistance: Rationale
for combination chemotherapy for malaria, Parasitology Today, 1996, 12:399–401.

116